Schrodinger: A Computational Platform That Is Likely Becoming Obsolete (SDGR)

~UserGI15994093/iStock via Getty Images Introduction Schrodinger (NASDAQ:SDGR) is a computational biology platform that uses a physics-informed algorithm, free energy perturbation (FEP), combined with machine learning to design drugs. In addition to licensing its code out to pharmaceutical companies, the company operates a partnership model, where SDGR will leverage its software and take equity or cash…

Read More